triamcinolone: Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block

Sponsor
ghada fouad (Other)
Overall Status
Completed
CT.gov ID
NCT04480775
Collaborator
(none)
84
1
3
5
16.7

Study Details

Study Description

Brief Summary

In the current Study we will compare between triamcinolone and methylprednisolone as an additive to bupivacaine drug in ultrasound guided TAP block in major open abdominal surgery .

Condition or Disease Intervention/Treatment Phase
Phase 2/Phase 3

Detailed Description

Postoperative pain is one of the main causes of respiratory function derangement after abdominal surgery .Transversus abdominis plane (TAP) block is widely used in abdominal surgery for postoperative analgesia The transversus abdominis plane (TAP) block is aperipheral nerve block that involves the injection of alocal anesthetic (LA) in the plane between the internaloblique and transversus abdominis muscle layers, with the aim of anesthetizing the intercostal nerves supplyingthe abdominal wall (from T6 to L1) By blocking intercostal nerves T6 to L1, TAPblock efficiently blocks somatic pain after abdominalwall surgery

. It providesadequate postoperative pain relief following various abdominal surgeries TAP block can reduce pain scores, opioid consumption, and the incidence of opioid-related complications after abdominal surgery.

The duration of the TAP block is limited to theeffect of the administered LAs. Various adjuvantmedications have been added to the LA to prolong theduration of TAP block and magnify its effects .

Perineural injection of steroids is reported to influence postoperative analgesia.

As a synthetic glucocorticoid, triamcinolone acetonide binds to and activates the glucocorticoid receptor to produce anti-inflammatory responses,such as down-regulating pro-inflammatory cytokine expression , preventing prostaglandin and leukotriene synthesis and release of arachidonic acid, and activating anti-inflammatory transcription factors such as lipocortins

Study Design

Study Type:
Interventional
Actual Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patient will be evaluated pre operative and full lab will be done In the Pre Anaesthesia Room ,a 20 gauge venous catheter will be inserted in the upper limb , and monitoring included heart rate, electrocardiogram, noninvasiveblood pressure, and peripheral oxygen saturation.Oxygen at the rate of 6 L/min will beadministered through oxygen mask to all patients. The anesthesiologist who performed the block will be blinded to drug solution and not involved in data collection, another anesthesiologist will prepare drug solution and other anesthesiologist collect the data.Patient will be evaluated pre operative and full lab will be done In the Pre Anaesthesia Room ,a 20 gauge venous catheter will be inserted in the upper limb , and monitoring included heart rate, electrocardiogram, noninvasiveblood pressure, and peripheral oxygen saturation.Oxygen at the rate of 6 L/min will beadministered through oxygen mask to all patients. The anesthesiologist who performed the block will be blinded to drug solution and not involved in data collection, another anesthesiologist will prepare drug solution and other anesthesiologist collect the data.
Masking:
Double (Participant, Investigator)
Masking Description:
double blinded
Primary Purpose:
Prevention
Official Title:
Triamcinolone Versus Methylprednisolone in Ultrasound Guided Transversus Abdominis Plane Block in Major Open Abdominal Surgery
Actual Study Start Date :
Jul 15, 2020
Actual Primary Completion Date :
Dec 15, 2020
Actual Study Completion Date :
Dec 15, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: bupivacaine group

28 Patients will receive 18 ml of bupivacaine 0.5 % plus 1ml 0.9% saline in TAP block divided equally on both sides

Drug: bupivacaine
transversus abdominis plane block with bupivacaine alone

Active Comparator: triamicinolone group

28 Patient will receive 18 ml of bupivacaine 0.5 % plus (20 mg of triamcinolone in 1ml 0.9% saline divided equally on both sides in TAP block

Drug: Triamcinolone
transversus abdominis plane block with bupivacain and triamicinolone

Drug: bupivacaine
transversus abdominis plane block with bupivacaine alone

Active Comparator: methylprednisolone group

28 Patient will receive 18 ml of bupivacaine 0.5 % plus (40 mg of methylprednisolone in 1ml 0.9% saline ) on both sides in TAP block.

Drug: Methylprednisolone
transversus abdominis plane block with bupivacaine and methylprednisolone

Drug: bupivacaine
transversus abdominis plane block with bupivacaine alone

Outcome Measures

Primary Outcome Measures

  1. analgesic effect of Triamcinolone and Methylprednisolone In Ultrasound Guided Transversus Abdominis Plane Block ( Tap Block ). [24 hours after surgery]

    visual analogue scale for assessement of pain from 0 to 10 is used where 0 is no pain and 10 is maximum pain

Secondary Outcome Measures

  1. occurance of complication [24 hours after surgery]

    nausea vomiting hemodynamic changes

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients scheduled for major open abdominal surgery

  • American Society Anesthesiologists (ASA) physical status I to II

Exclusion Criteria:
  • Patient refusal.

  • Morbidly obese patients.

  • Patients with uncontrolled diabetes.

  • Severe or uncontrolled renal, hepatic or endocrinal diseases.

  • Pregnancy, post-partum or lactating females

  • Allergy to one of the agents used.

  • Recent (less than six months) use of glucocorticoids for at least two weeks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura University Mansoura Egypt

Sponsors and Collaborators

  • ghada fouad

Investigators

  • Principal Investigator: marwa M elegemazy, master, Mansoura University
  • Study Director: ghada f amer, M.D, associate professor of anesthesia
  • Study Chair: Eiad a ramzy, M.D, associate professor of anesthesia
  • Study Chair: abdelaziz a motaweaa, M.D, professor of anesthesia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ghada fouad, associate professor, Mansoura University
ClinicalTrials.gov Identifier:
NCT04480775
Other Study ID Numbers:
  • (MS.20.01.999-2020/01/10)
First Posted:
Jul 21, 2020
Last Update Posted:
Mar 3, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by ghada fouad, associate professor, Mansoura University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2021